Transfusion-associated graft-versus-host disease

Tipu, 2008, Transfusion associated graft versus host disease, J Pak Med Assoc, 5, 143 Triulzi, 2006, Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells, Transfusion, 46, 885, 10.1111/j.1537-2995.2006.00819.x Aoun, 2003, Transfusion associated GVHD: 10years’ experience at the American University of Beirut Medical Center, Transfusion, 43, 1672, 10.1046/j.0041-1132.2003.00578.x Hutchinson, 2002, Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation, Transfusion, 42, 1567, 10.1046/j.1537-2995.2002.00253.x Utter, 2008, Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts, Transfusion, 48, 1609, 10.1111/j.1537-2995.2008.01758.x Patel, 2010, Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient, Indian J Hematol Blood Transfus, 26, 92, 10.1007/s12288-010-0028-0 Takahashi, 1994, Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group, Lancet, 343, 700, 10.1016/S0140-6736(94)91580-6 Leitman, 2003, Transfusion associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus, Transfusion, 43, 1667, 10.1046/j.0041-1132.2003.00579.x Butcher, 2004, Stress responses and innate immunity: aging as a contributory factor, Aging Cell, 3, 151, 10.1111/j.1474-9728.2004.00103.x Alter, 2008, The hazards of blood transfusion in historical perspective, Blood, 112, 2617, 10.1182/blood-2008-07-077370 Dwyre, 2008, Transfusion-associated graft-versushost disease, Vox Sang, 95, 85, 10.1111/j.1423-0410.2008.01073.x Agbaht, 2007, Transfusion associated graft-versus-host disease in immunocompetent patients: case series and review of literature, Transfusion, 47, 1405, 10.1111/j.1537-2995.2007.01282.x Wagner, 1995, Transfusion-associated graft versus host disease: risk due to homozygous HLA haplotypes, Transfusion, 35, 284, 10.1046/j.1537-2995.1995.35495216075.x Warren, 1999, DNA polymorphism analysis in transfusion-associated graft-versus-host disease, J Paediatr Child Health, 35, 98, 10.1046/j.1440-1754.1999.00345.x Higgins, 2005, Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion, Curr Hematol Rep, 4, 470